Bioengineering is a multidisciplinary field that merges engineering principles with biology to tackle complex challenges in healthcare and other domains. It encompasses the design, development, and application of innovative technologies, devices, and processes to advance medical research, diagnostics, treatments, and stem cell research. Bioengineers integrate their expertise in engineering, biology, and other relevant disciplines to create solutions that enhance patient outcomes, improve quality of life, and promote sustainability. Through the utilization of cutting-edge technology and scientific knowledge, bioengineering drives progress in areas such as regenerative medicine, tissue engineering, medical imaging, drug delivery systems, and stem cell-based therapies.
The Importance of Biotechnology and Bioengineering
Biotechnology and bioengineering play a crucial role in advancing healthcare, agriculture, and environmental sustainability. These fields enable the development of innovative therapies, diagnostic tools, and sustainable agricultural practices. They contribute to precision medicine by tailoring medical interventions to individual patients, while also improving crop yields, disease resistance, and nutritional value. Biotechnology and bioengineering research drive economic growth, foster scientific knowledge, and address ethical considerations in the use of genetic information and biotechnological interventions. Their importance lies in their potential to revolutionize industries, enhance human well-being, and create a more sustainable and personalized future.
Defining Stem Cells: What You Need To Know About Stem Cell Research
Stem cells are unique cells that have the remarkable ability to develop into different cell types in the body. They are characterized by their self-renewal and differentiation potential. There are different types of stem cells, including embryonic stem cells derived from early-stage embryos and adult stem cells found in various tissues throughout the body. Stem cells play a crucial role in development, growth, and tissue repair. They have significant therapeutic potential for regenerative medicine, as they can be used to replace damaged cells, generate new tissues, and treat a range of diseases and injuries. Ongoing stem cell research is focused on harnessing the power of stem cells to develop effective treatments for conditions such as spinal cord injuries, heart disease, neurodegenerative disorders, and diabetes.
On The Rise: Stem Cell Market Growth
The stem cell market is a rapidly growing sector within the biotechnology and healthcare industries. It encompasses various products, services, and therapies related to the use of stem cells. The market includes areas such as stem cell research tools, stem cell banking and storage, stem cell therapies, and regenerative medicine products. The increasing prevalence of chronic diseases, advancements in stem cell technologies, and a growing aging population are driving the expansion of the stem cell market. Additionally, collaborations between research institutions, pharmaceutical companies, and government initiatives are further propelling the market's growth and commercialization of stem cell-based therapies.
The stem cell therapy market is expected to experience meteoric growth over the next few years. A report from Grand View Research projects that the stem cell market will reach US$18.4 billion by 2028.
Bioengineering Leaders: Stem Cell Companies that are Spearheading Innovation
Here are 20 innovative stem cell companies in the US:
Located in La Jolla, California, Aspen Neuroscience develops autologous cell treatments and tailored medicines for various disorders, beginning with Parkinson's disease. The company's platform combines cutting-edge genomic AI with pluripotent stem cell biology to deliver patient-specific restorative cell therapy that alters disease progression.
Located in Cambridge, Massachusetts, Magenta Therapeutics is working on new drugs to boost stem cell transplant, gene therapy, genome editing, and cell therapy's curative abilities.
Executive Vice President, Research and Development - Francois Binette
Located in Los Angeles, California, Enochian Biosciences focuses on finding, developing, manufacturing, and marketing gene treatments. It researches and develops cures for infectious diseases and cancer. It is also working on HIV vaccines and treatments, as well as cellular immuno-oncology medicines.
Located in Cambridge, Massachusetts, Rubius Therapeutics is developing red cell therapeutics (RCTs) to treat uncommon disorders, cancer, and autoimmune diseases.
Located in Seattle, Washington, Sana Biotechnology is dedicated to developing modified cells as therapeutics for patients. They are developing pluripotent stem cells with the goal of replacing any missing or damaged cells in the body, is the next step and creating new delivery methods to deliver any payload to any cell in a precise, predictable, and repeatable manner, opening the way for next-generation in vivo gene therapy.
Located in Des Moines, Iowa, Regenexx has invented a patented orthopedic technique to lower orthopedic costs and improve patient results. The company has created several processing and treatment methodologies and published about half of all studies on the use of mesenchymal stem cells for the treatment of orthopedic injuries, allowing clinicians to treat orthopedic injuries.
Located in San Diego, CA, Fate Therapeutics works on cancer and immunological illnesses by developing programmed cellular immunotherapies. NK- and T-cell immuno-oncology initiatives, including off-the-shelf engineered product candidates produced from clonal master iPSC lines, and immuno-regulatory programs, make up the company's cell therapy pipeline.
Located in Cambridge, Massachusetts, Cellino uses image-guided machine learning, single-cell laser processing, and robotics to create autologous induced pluripotent stem cells (iPSCs) at scale, allowing healthcare professionals to speed up the creation of life-saving medications for patients.
Located in Newark, California, Protagonist Therapeutics has developed a patented technology platform to meet large unmet medical needs. The company's current pipeline includes Rusfertide (PTG-300), an injectable hepcidin mimetic currently in a Phase 2 proof-of-concept clinical trial for polycythemia vera, a type of blood cancer.
Located in Maple Grove, Minnesota, StemoniX has developed a human-induced cardiac screening tool with the goal of improving and speeding up neurotoxicity research and medication testing. The company's platform develops novel cell-based illness models and scales up bespoke human iPSC disease models for high-throughput screening, allowing scientists to perform research more rapidly and efficiently with better results.
Located in Boston, Massachusetts, Vertex Pharmaceuticals, researches and develops small-molecule medications for treating critical illnesses. Vertex is diversifying its pipeline beyond cystic fibrosis with gene-editing therapies including CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors for acute and chronic pain utilizing non-opioid treatments.
Located in Cambridge, Massachusetts, Intellia Therapeutics specializes in genome editing. Its primary goal is to produce exclusive CRISPR/Cas9-based therapies with the potential to be curative. Its collaboration with Novartis, includes the ex vivo development of innovative cell therapies using certain ocular stem cells.
Located in Hampton, New Jersey, Celldex Therapeutics focuses on the development and commercialization of a variety of immunotherapy technologies as well as other cancer-targeting biologics. Varlilumab, CDX-301, CDX-1140, CDX-0159/Anti-KIT Program, and CDX-527 are among the company's pipeline products.
Located in Florham Park, New Jersey, Celularity, is developing off-the-shelf placental-derived allogeneic cell therapies, such as genetically modified and unmodified NK cells, engineered T cells, including CAR-T cells, and mesenchymal-like adherent stromal cells, for cancer, immunology, infectious, and degenerative diseases.
Located in Philadelphia, Pennsylvania Century Therapeutics creates PSCs-derived immune effector cell products designed to target solid tumors and hematological cancers.
Located in San Diego, California, ViaCyte, develops innovative cell replacement techniques and regenerative medicine to treat serious human diseases and disorders. The company's therapies are based on two important technological advances: pluripotent stem cell-derived cell replacement therapies and medical device systems for cell encapsulation and implantation.
Located in Seattle, Washington, Curi Bio develops biomimetic cultureware by integrating human cells and data. The company provides products for drug discovery cell and tissue engineering that promotes in vivo maturation which helps drug developers test the efficacy of new drugs.
Located in Lexington, Massachusetts, Frequency Therapeutics, that aims to use the body's own biology to heal or cure degenerative disease damage. Its Progenitor Cell Activation method activates progenitor cells in the body to build functional tissue by combining chemicals.
Located in Cambridge, Massachusetts, Garuda Therapeutics utilizes mice, zebrafish, and human-induced pluripotent stem cells to develop mechanism-based therapies. These therapies are used to treat patients suffering from immune, bone marrow, and metabolic diseases.
Located in Cleveland, Ohio, Athersys, primary focus is on the development of unique and patented medicines in areas where there is an unmet medical need, particularly in the field of regenerative medicine. Multistem cell treatment is the company's principal product aimed at treating neurological illnesses, cardiovascular disease, inflammatory and immunological disorders, and some pulmonary disorders.
Scispot has Advanced Lab Operations Technology that Empowers Bioengineers and Stem Cell Companies
Scispot is on a mission to empower bioentrepreneurs and make workflow automation possible for every life science lab on this planet. To learn more about Scispot and its no-code digital toolkit for lab digitalization and automation, book a demo here.
The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.
Static and dynamic content editing
A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!
How to customize formatting for each rich text
Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.
.png)
